search button
Open Access

The association between CD69 and EGR1 levels, and CHD patients without reflow after PCI

  • Authors:
    • Yi Xiang
    • Jianqiao Peng
    • Qiong Liu
    • Chun Guo

  • View Affiliations

  • Published online on: March 19, 2019     https://doi.org/10.3892/etm.2019.7411
  • Pages: 3913-3920

  • Copyright: © Xiang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Association between CD69 and EGR1 levels and coronary heart disease (CHD) patients without reflow after percutaneous coronary intervention (PCI) was investigated. Data of 156 patients undergoing PCI from September 2014 to December 2016 in People's Hospital of Hunan Province were analyzed, and they were divided into 72 cases in reflow group (group A) and 84 cases in no-reflow group (group B) according to the patient's postoperative blood flow. Another 70 volunteers undergoing normal physical examination in the same period were selected as control group (group C). The venous blood was extracted from patients before operation, at 5 min, 2 h and 6 months after operation, the serum CD69 and EGR1 levels were detected with flow cytometry and RT‑qPCR methods, and association between CD69 and EGR1 levels and postoperative blood flow recovery was analyzed. CD69 expression before and 2 h after operation in group A was significant (P<0.05), and a difference in patients at 6 months after operation between group A, B and group C (P<0.05). The CD69 expression in group A was significantly lower than that in group B (P<0.05), but in group B was significantly higher than that in group C (P<0.05). The EGR1 expression in group A was significantly higher than that in group B (P<0.05), but in group B was significantly lower than that in group C (P<0.05). Multivariate logistic regression analysis revealed that CD69 (OR=6.424, P=0.025) and EGR1 (OR=3.684, P=0.013) were independent risk factors for patients without reflow after undergoing PCI. After undergoing PCI in CHD patients, if there was an increase in CD69 level and a significant decrease in EGR1 level in the early postoperative period, the patient may be suspected of having no-reflow and checked in time to improve the patient's therapeutic effect.
View Figures
View References

Related Articles

Journal Cover

May-2019
Volume 17 Issue 5

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 2.4
  • Ranked Medicine Research and Experimental
    (total number of cites)
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Xiang Y, Peng J, Liu Q and Guo C: The association between CD69 and EGR1 levels, and CHD patients without reflow after PCI. Exp Ther Med 17: 3913-3920, 2019.
APA
Xiang, Y., Peng, J., Liu, Q., & Guo, C. (2019). The association between CD69 and EGR1 levels, and CHD patients without reflow after PCI. Experimental and Therapeutic Medicine, 17, 3913-3920. https://doi.org/10.3892/etm.2019.7411
MLA
Xiang, Y., Peng, J., Liu, Q., Guo, C."The association between CD69 and EGR1 levels, and CHD patients without reflow after PCI". Experimental and Therapeutic Medicine 17.5 (2019): 3913-3920.
Chicago
Xiang, Y., Peng, J., Liu, Q., Guo, C."The association between CD69 and EGR1 levels, and CHD patients without reflow after PCI". Experimental and Therapeutic Medicine 17, no. 5 (2019): 3913-3920. https://doi.org/10.3892/etm.2019.7411